BIG WINNER !!!!!!!!
Delivra Receiving Interest for its Expertise and Technology for Use in the Cannabis and Pharma Industries TORONTO, Oct. 1, 2018 /CNW/ - Delivra Corp. (TSXV: DVA - "Delivra" or the "Company"), a scientific and biotechnology company, today announced that it has recently received inquiries from a number of interested parties in relation to the Company's proprietary transdermal delivery system platform, including its proprietary applications for the cannabis and pharma industries. As a result of these inquiries, the Company has engaged Canaccord Genuity Corp. to act as exclusive financial advisor to identify, review, analyze and explore the range of strategic and other opportunities available to the Company within the cannabis and pharma industries. There can be no assurance that the Company will enter into any transaction, that there will be any change in the operation or ownership of the Company, or that the Company will take any other corporate action as a result of the review. Delivra has not set a timetable for completion of the review process and it does not intend to disclose further developments with respect to the review unless and until required by law or until such disclosure is deemed appropriate by the Company. Delivra cautions that there are no guarantees that the process will result in a transaction of any kind, and if a transaction is undertaken, that there is no guarantee as to its terms or timing. Read more at https://www.stockhouse.com/companies/bullboard/v.dva/delivra-corp?postid=28723635#plBi28GTEyHp6OwJ.99